Berkeley Tenure Tiff Restarts GM Food Joust

In early June, University of California, Berkeley, assistant professor Ignacio Chapela moved his office chair to the main quad of the campus and started conducting his affairs in public. Yes, Berkeley has nice enough weather to work outside, but Chapela was not there for the sunshine. He was staging a protest to decry his lack of tenure. Chapela's protest did not last more than a few days. He returned to his air- conditioned office after getting a promise of fair treatment from the chancello

Written bySam Jaffe
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

In early June, University of California, Berkeley, assistant professor Ignacio Chapela moved his office chair to the main quad of the campus and started conducting his affairs in public. Yes, Berkeley has nice enough weather to work outside, but Chapela was not there for the sunshine. He was staging a protest to decry his lack of tenure.

Chapela's protest did not last more than a few days. He returned to his air- conditioned office after getting a promise of fair treatment from the chancellor and a year-long extension of his assistant professorship, after which a final tenure decision will be made. The dispute underlying the affair still simmers, however.

At the heart of Chapela's saga is a paper he coauthored with one of his graduate students, David Quist, published in Nature.1 In the paper, Quist and Chapela claimed they had discovered genetically engineered genes in native Mexican corn fields, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies